Which statement is true about tPA therapy?

Prepare for the NCLEX exam effectively with our NCLEX Uworld Practice Test. Use flashcards and multiple choice questions with detailed hints and explanations to ensure you're ready for success!

Multiple Choice

Which statement is true about tPA therapy?

Explanation:
tPA is a thrombolytic that activates plasmin to break down fibrin and dissolve clots. It doesn’t remove every clot everywhere in the body and is used in specific acute settings within a defined time window, not as a blanket dissolver for all clots. Because it promotes bleeding, conditions that raise bleeding risk are contraindications; thrombocytopenia, with low platelets, significantly increases bleeding risk, making tPA unsafe in that situation. It’s not used to treat infection, and while bleeding is the major concern with tPA, it isn’t a medication chosen to raise blood pressure. Therefore, being contraindicated with thrombocytopenia is the true statement about tPA therapy.

tPA is a thrombolytic that activates plasmin to break down fibrin and dissolve clots. It doesn’t remove every clot everywhere in the body and is used in specific acute settings within a defined time window, not as a blanket dissolver for all clots. Because it promotes bleeding, conditions that raise bleeding risk are contraindications; thrombocytopenia, with low platelets, significantly increases bleeding risk, making tPA unsafe in that situation. It’s not used to treat infection, and while bleeding is the major concern with tPA, it isn’t a medication chosen to raise blood pressure. Therefore, being contraindicated with thrombocytopenia is the true statement about tPA therapy.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy